Article
Roche to read out even more data on megablockbuster Ocrevus in MS
Rating:
0.0
Views:
67
Likes:
1
Library:
1
It's been three years since Roche hit the market with its megablockbuster MS drug Ocrevus — but the Swiss pharma isn't done building on the program that CEO Severin Schwan has called the most successful launch in the company's 124-year history. Roche says it's going to MSVirtual2020 next weekend with
Rate This Post
Rate The Educational Value
Rate The Ease of Understanding and Presentation
Interesting or Boring? Rate the Entertainment Value